AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28118028 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT)
Number of subjects: 59
Study 28118028 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection margin (RM) status
Number of subjects: 59
Study 24990029 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 17
Study 24990029 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal healthy persons), n = 12
Number of subjects: 17
Study 22230331 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftobiprole
Number of subjects: 706
Study 22230331 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone ± linezolid (comparator)
Number of subjects: 706
Study 20346048 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive multimedia presentation (IMP)
Number of subjects: 40
Study 20346048 — intervention group
Group type: COMPARATOR
Intervention: Standard consent (SC)
Number of subjects: 40
Study 18705234 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive dressing (containing hydrophilic mucopolysaccharide, chitosan)
Number of subjects: 85
Study 18705234 — intervention group
Group type: COMPARATOR
Intervention: Control dressing (gauze)
Number of subjects: 85
Study 15615803 — intervention group
Group type: EXPERIMENTAL
Intervention: Idiopathic pulmonary embolism
Number of subjects: 360
Study 15615803 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary embolism associated with transient risk factors
Number of subjects: 360
Study 15615803 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 360
Study 14500110 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 28
Study 14500110 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 28
Study 14500110 — intervention group
Group type: COMPARATOR
Intervention: Healthy Control
Number of subjects: 28
Study 10562784 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 0.3-3.0 mg kg-1 administered pre-emptively i.v. during operation
Number of subjects: 611
Study 10562784 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl i.v. for rescue analgesia
Number of subjects: 611
Study 7479422 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 4500
Study 7479422 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 4500
Study 2110787 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular lorazepam
Number of subjects: 30
Study 2110787 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular morphine and hyoscine (scopolamine)
Number of subjects: 30
Study 2110787 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lorazepam plus intramuscular morphine and hyoscine
Number of subjects: 30
Study 426499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephradine (2 to 4 g per day, administered by intravenous injection in four equally divided doses for a minimum of 4 days)
Number of subjects: 180
Study 426499 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin (2 to 4 g per day, administered by intravenous injection in four equally divided doses for a minimum of 4 days)
Number of subjects: 180
Study 31213163 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery endothelial shear stress in migraine patients
Number of subjects: 40
Study 28780364 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 102
Study 28780364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 26386824 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater neighborhood physical order
Number of subjects: 139
Study 26386824 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater neighborhood social order
Number of subjects: 139
Study 26386824 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater perceived physical disorder
Number of subjects: 139
Study 26386824 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater perceived social disorder
Number of subjects: 139
Study 26386824 — intervention group
Group type: EXPERIMENTAL
Intervention: Total neighborhood disorder
Number of subjects: 139
Study 26386824 — intervention group
Group type: EXPERIMENTAL
Intervention: Social disorder
Number of subjects: 139
Study 26386824 — intervention group
Group type: EXPERIMENTAL
Intervention: Social order
Number of subjects: 139
Study 22836859 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (<20 g of fat/d) for 4 weeks in the suggestive group
Number of subjects: 45
Study 22836859 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (<20 g of fat/d) for 4 weeks in the indeterminate group
Number of subjects: 45
Study 22836859 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 or less minor features of chronic pancreatitis)
Number of subjects: 45
Study 21329887 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 40
Study 21329887 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil
Number of subjects: 40
Study 21329887 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 40
Study 21329887 — intervention group
Group type: COMPARATOR
Intervention: Sham (Group 5)
Number of subjects: 40
Study 21329887 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (PUUO without treatment)
Number of subjects: 40
Study 19217992 — intervention group
Group type: COMPARATOR
Intervention: Below-knee cast
Number of subjects: 584
Study 19217992 — intervention group
Group type: COMPARATOR
Intervention: Aircast brace
Number of subjects: 584
Study 19217992 — intervention group
Group type: COMPARATOR
Intervention: Bledsoe boot
Number of subjects: 584
Study 19217992 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubular compression bandage
Number of subjects: 584
Study 17277040 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined calcium and vitamin D supplementation (500 mg calcium citrate and 700 IU vitamin D(3) daily for 3 years)
Number of subjects: 314
Study 17277040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 15104610 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical hysterectomy
Number of subjects: 41
Study 15104610 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple hysterectomy
Number of subjects: 41
Study 15104610 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 41
Study 15104610 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 41
Study 11288011 — intervention group
Group type: EXPERIMENTAL
Intervention: Reviparin (low-molecular weight heparin) administered once daily subcutaneously for 7 to 10 days
Number of subjects: 262
Study 11288011 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 262
Study 10423639 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg melatonin
Number of subjects: 21
Study 10423639 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg melatonin
Number of subjects: 21
Study 10423639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 7955250 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservation of chordae tendineae and papillary muscles during mitral valve replacement (Pres group)
Number of subjects: 16
Study 7955250 — intervention group
Group type: COMPARATOR
Intervention: No preservation of chordae tendineae and papillary muscles during mitral valve replacement (No Pres group)
Number of subjects: 16
Study 3297467 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine
Number of subjects: 16
Study 3297467 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine + oral captopril (50 mg)
Number of subjects: 16
Study 3297467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31985094 — intervention group
Group type: EXPERIMENTAL
Intervention: Kakato-tsurutsuru (Kt) socks
Number of subjects: 10
Study 31985094 — intervention group
Group type: COMPARATOR
Intervention: Control socks
Number of subjects: 10
Study 29317046 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified technique with ice bag
Number of subjects: 21
Study 29317046 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard technique)
Number of subjects: 21
Study 26860796 — intervention group
Group type: EXPERIMENTAL
Intervention: JianYuTangKang (JYTK) plus metformin
Number of subjects: 112
Study 26860796 — intervention group
Group type: COMPARATOR
Intervention: Metformin plus placebo
Number of subjects: 112
Study 23402523 — intervention group
Group type: EXPERIMENTAL
Intervention: Work and Social Adjustment Scale (WSAS)
Number of subjects: 73
Study 23171519 — intervention group
Group type: EXPERIMENTAL
Intervention: +NL
Number of subjects: 23000
Study 23171519 — intervention group
Group type: COMPARATOR
Intervention: ‐NL
Number of subjects: 23000
Study 23171519 — intervention group
Group type: EXPERIMENTAL
Intervention: +SB
Number of subjects: 23000
Study 23171519 — intervention group
Group type: COMPARATOR
Intervention: ‐SB
Number of subjects: 23000
Study 20620119 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Interactive Voice Response (TIVR) program for 4 months
Number of subjects: 51
Study 20620119 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up care only (Control)
Number of subjects: 51
Study 18467730 — intervention group
Group type: EXPERIMENTAL
Intervention: Current therapy
Number of subjects: 788
Study 16898274 — intervention group
Group type: EXPERIMENTAL
Intervention: Faded knowledge of results (KR) frequency during observation of a model's performance
Number of subjects: 0
Study 16898274 — intervention group
Group type: COMPARATOR
Intervention: Knowledge of results (KR) on each trial
Number of subjects: 0
Study 12910567 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 international units of human IFN alfa administered oromucosally 3 times per day for 24 weeks
Number of subjects: 497
Study 12910567 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 497
Study 12910567 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IFN alfa and placebo)
Number of subjects: 497
Study 10781467 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg spinal bupivacaine
Number of subjects: 45
Study 10781467 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg spinal bupivacaine
Number of subjects: 45
Study 10781467 — intervention group
Group type: COMPARATOR
Intervention: 0.75% hyperbaric bupivacaine
Number of subjects: 45
Study 8620278 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy
Number of subjects: 24
Study 8620278 — intervention group
Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 24
Study 1485370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone (4.6-7.3 mg)
Number of subjects: 48
Study 1485370 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxycodone tablets (9.1 mg)
Number of subjects: 48
Study 1485370 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxycodone syrup (9.1 mg)
Number of subjects: 48
Study 1485370 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal oxycodone suppository (30 mg)
Number of subjects: 48
Study 2858149 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure in vivo
Number of subjects: 115
Study 2858149 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive therapy of dynamic type or simple basal therapy
Number of subjects: 115
Study 30720931 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Daprodustat (1.0% at 100 mg/cm2 for 14 days)
Number of subjects: 0
Study 30720931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30720931 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 0
Study 30115263 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal clear fluid intake until premedication with midazolam
Number of subjects: 162
Study 30115263 — intervention group
Group type: COMPARATOR
Intervention: Standard 2 h fluid fasting
Number of subjects: 162
Study 26712714 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy (100 mJ/pin)
Number of subjects: 30
Study 26712714 — intervention group
Group type: COMPARATOR
Intervention: Moderate energy (60 mJ/pin)
Number of subjects: 30
Study 24944057 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-HPWL diet
Number of subjects: 20
Study 24944057 — intervention group
Group type: COMPARATOR
Intervention: Meat-HPWL diet
Number of subjects: 20
Study 22149337 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecallantide, a potent and specific plasma kallikrein inhibitor, administered subcutaneously.
Number of subjects: 0
Study 22149337 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 19156709 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants augmented with atypical antipsychotics (AAP) for more than 2 weeks (n = 100)
Number of subjects: 272
Study 19156709 — intervention group
Group type: COMPARATOR
Intervention: Antidepressants only (non‐AAP group, n = 172)
Number of subjects: 272
Study 19156709 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs with AAP (n unspecified)
Number of subjects: 272
Study 19156709 — intervention group
Group type: COMPARATOR
Intervention: SSRIs without AAP (n unspecified)
Number of subjects: 272
Study 19156709 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs and olanzapine (n unspecified)
Number of subjects: 272
Study 17548728 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels > or = 12.11 nmol/L at 7 days after ACS
Number of subjects: 3946
Study 17548728 — intervention group
Group type: EXPERIMENTAL
Intervention: Neopterin levels > or = 12.11 nmol/L at 4 months after ACS
Number of subjects: 3946
Study 17548728 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin among subjects with neopterin levels > or = 12.11 nmol/L at baseline
Number of subjects: 3946
Study 14981383 — intervention group
Group type: EXPERIMENTAL
Intervention: Opinion leader strategy intervention
Number of subjects: 18
Study 14981383 — intervention group
Group type: COMPARATOR
Intervention: Control group hospitals
Number of subjects: 18
Study 11246058 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (160 mg/d)
Number of subjects: 42
Study 11246058 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (INR 2.8‐4.2)
Number of subjects: 42
Study 11246058 — intervention group
Group type: COMPARATOR
Intervention: Combination of aspirin (75 mg/d) and warfarin (INR 2.0‐2.5)
Number of subjects: 42
Study 9676516 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted learning software 'Let's Play With...'
Number of subjects: 60
Study 9676516 — intervention group
Group type: COMPARATOR
Intervention: Standard drill-and-practice methods
Number of subjects: 60
Study 7978533 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of H1 and H2 histamine antagonists and a corticosteroid in gelatin capsules
Number of subjects: 22
Study 7978533 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 22
Study 7978533 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (premedication)
Number of subjects: 22
Study 2692344 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg
Number of subjects: 36
Study 2692344 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac-Na 100 mg
Number of subjects: 36
Study 29354937 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture technique (once a day for 15 days, 3 courses)
Number of subjects: 56
Study 29354937 — intervention group
Group type: COMPARATOR
Intervention: Routine basic rehabilitation therapy
Number of subjects: 56
Study 27484021 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin peglispro (BIL)
Number of subjects: 4927
Study 27484021 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 4927
Study 27484021 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal-bolus therapy
Number of subjects: 4927
Study 25626750 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (self-explanation with examples and prompts)
Number of subjects: 54
Study 25626750 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (self-explanation with examples without prompts)
Number of subjects: 54
Study 25626750 — intervention group
Group type: COMPARATOR
Intervention: Control group (solved word puzzles)
Number of subjects: 54
Study 23333095 — intervention group
Group type: EXPERIMENTAL
Intervention: High polyphenol olive oil (961 mg/kg)
Number of subjects: 13
Study 23333095 — intervention group
Group type: COMPARATOR
Intervention: Moderate polyphenol olive oil (289 mg/kg)
Number of subjects: 13
Study 20687956 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural interventions delivered in general practice including lifestyle counselling and motivational interviewing, diet education, and physical activity program consisting of two individual visits with a dietician or exercise physiologist and four group sessions.
Number of subjects: 1200
Study 20687956 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard care without the additional behavioural interventions.
Number of subjects: 1200
Study 18771406 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 140 0.5 mg/kg
Number of subjects: 39
Study 18771406 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 140 2 mg/kg
Number of subjects: 39
Study 18771406 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 140 5 mg/kg
Number of subjects: 39
Study 18771406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 16157085 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethically justified guidelines for pharmacologic research involving pregnant women
Number of subjects: 0
Study 16157085 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent process shaped by pregnant patient's obligation to fetal patient
Number of subjects: 0
Study 16157085 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral of pregnant women to trials by physicians
Number of subjects: 0
Study 15048595 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon therapy
Number of subjects: 19
Study 15048595 — intervention group
Group type: COMPARATOR
Intervention: Control (no interferon)
Number of subjects: 19
Study 9892407 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of upper respiratory tract swab samples and cerebrospinal fluid (CSF) samples
Number of subjects: 100
Study 9892407 — intervention group
Group type: COMPARATOR
Intervention: Cerebrospinal fluid (CSF) samples alone
Number of subjects: 100
Study 9892407 — intervention group
Group type: COMPARATOR
Intervention: Respiratory tract samples in control group
Number of subjects: 100
Study 8688387 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose aspirin (60 mg daily)
Number of subjects: 60
Study 8688387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 1864027 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EA)
Number of subjects: 72
Study 1864027 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 72
Study 1864027 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral vein clot
Number of subjects: 72
Study 6357273 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acyclovir
Number of subjects: 40
Study 6357273 — intervention group
Group type: COMPARATOR
Intervention: Topical steroids
Number of subjects: 40
Study 30444150 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ HDM SLIT-tablet (5000, 10,000, or 20,000 JAU) for 14 days
Number of subjects: 48
Study 30444150 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ HDM SLIT-tablet (up-dosing regimen: 5,000 JAU on days 1-3, 10,000 JAU on days 4-7, 20,000 JAU on days 8-14) for 14 days
Number of subjects: 48
Study 30444150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 29288190 — intervention group
Group type: COMPARATOR
Intervention: Standard TME surgery (control)
Number of subjects: 0
Study 29288190 — intervention group
Group type: EXPERIMENTAL
Intervention: Organ-saving treatment using long-course concurrent chemoradiation
Number of subjects: 0
Study 29288190 — intervention group
Group type: EXPERIMENTAL
Intervention: Organ-saving treatment using short-course radiotherapy
Number of subjects: 0
Study 29288190 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance regime in case of complete clinical regression
Number of subjects: 0
Study 29288190 — intervention group
Group type: EXPERIMENTAL
Intervention: Local excision using transanal endoscopic microsurgery or other transanal techniques in case of incomplete clinical regression
Number of subjects: 0
Study 26126563 — intervention group
Group type: EXPERIMENTAL
Intervention: Support from Aboriginal and Torres Strait Islander staff champions
Number of subjects: 53
Study 26126563 — intervention group
Group type: EXPERIMENTAL
Intervention: Research perceived to address a health priority for communities
Number of subjects: 53
Study 26126563 — intervention group
Group type: EXPERIMENTAL
Intervention: Onsite support from the research team
Number of subjects: 53
Study 26126563 — intervention group
Group type: EXPERIMENTAL
Intervention: Streamlined trial processes
Number of subjects: 53
Study 26126563 — intervention group
Group type: EXPERIMENTAL
Intervention: Major investments in time and resources
Number of subjects: 53
Study 24707863 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture (WAA)
Number of subjects: 60
Study 24707863 — intervention group
Group type: COMPARATOR
Intervention: Oral morphine sulphate (MOR)
Number of subjects: 60
Study 22978723 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RCA) in the region defined as ectopic focus by electrophysiology study (Group I)
Number of subjects: 20
Study 22978723 — intervention group
Group type: COMPARATOR
Intervention: High-amplitude pacing in the region of 'perfect' mapping (Group II)
Number of subjects: 20
Study 19173743 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro Emotional Technique (NET)
Number of subjects: 93
Study 19173743 — intervention group
Group type: COMPARATOR
Intervention: Sham NET (placebo)
Number of subjects: 93
Study 19173743 — intervention group
Group type: COMPARATOR
Intervention: Existing medical regimen (Control)
Number of subjects: 93
Study 15883209 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide-coated stents
Number of subjects: 92
Study 12646763 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) administration of 2 mg clonazepam
Number of subjects: 12
Study 12646763 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral (p.o.) administration of 2 mg clonazepam
Number of subjects: 12